- Security Type
- Non-Voting Equity
- Categories
- Technology
- Min Investment
- $228
- Location
-
Raleigh, NC
- Offering Date
- January 07, 2022
- Expected Close Date
- May 29, 2022
- Amount Raised
- $93,519
- Target Raise
- $10K-$1M
- No. Investors
- 61
- Security Price
- $2.85
- Valuation
- $89,300,000
Company Description
Scinovia’s mission is to produce state-of-the-art diagnostics to help doctors make more data-driven decisions during procedures to save more lives. Scinovia developed VUFLOW, the future of non-contact imaging diagnostics for blood flow during surgery.
Perks
StartEngine OWNERS Exclusive Click here to learn more
$498+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$1,500+ Investment
$1,500+ Tier
Invest $1,500+ and receive 15% bonus shares
$5,000+ Investment
$5,000+ Tier
Invest $5,000+ and receive 20% bonus shares
$25,000+ Investment
$25,000+ Tier
Invest $25,000+ and receive 25% bonus shares
$50,000+ Investment
$50,000+ Tier
Invest $50,000+ and receive 30% bonus shares
$100,000+ Investment
$100,000+ Tier
Invest $100,000+ and receive 40% bonus shares
$498+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$1,500+ Investment
$1,500+ Tier
Invest $1,500+ and receive 15% bonus shares
$5,000+ Investment
$5,000+ Tier
Invest $5,000+ and receive 20% bonus shares
$25,000+ Investment
$25,000+ Tier
Invest $25,000+ and receive 25% bonus shares
$50,000+ Investment
$50,000+ Tier
Invest $50,000+ and receive 30% bonus shares
$100,000+ Investment
$100,000+ Tier
Invest $100,000+ and receive 40% bonus shares
Key Deal Facts
Save more lives: A big challenge many surgeons face is knowing if procedures have optimal blood flow for quick recovery.
Disrupt a $500M market: Displace legacy contact probe* and dye* methods over past 60 years with VUFLOW, one of the first non-contact measurement device to visualize blood flow speeds in surface vessels during major surgeries.
Platform Technology: VUFLOW may be applicable to many types of surgeries. There are over 300M per year. Initial markets are heart bypass and organ transplants.
Security Description
Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.